Patents by Inventor Arno Mullbacher

Arno Mullbacher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Influenza vaccines
    Patent number: 10251947
    Abstract: The invention relates to a method for the treatment or prevention of an influenza virus infection in a subject, the method comprising administering to the subject a therapeutically effective amount of a gamma-irradiated influenza virus.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: April 9, 2019
    Assignee: Gamma Vaccines Pty Limited
    Inventors: Mohammed Alsharifi, Arno Mullbacher
  • INFLUENZA VACCINES
    Publication number: 20150283224
    Abstract: The invention relates to a method for the treatment or prevention of an influenza virus infection in a subject, the method comprising administering to the subject a therapeutically effective amount of a gamma-irradiated influenza virus.
    Type: Application
    Filed: June 19, 2015
    Publication date: October 8, 2015
    Inventors: Mohammed Alsharifi, Arno Mullbacher
  • COMBINATION VACCINES
    Publication number: 20140079732
    Abstract: The present invention relates to the field of vaccines. More specifically the present invention relates to compositions and methods for enhancing immune responses induced by vaccines, including vaccines targeted at secondary infections and conditions associated with influenza infection.
    Type: Application
    Filed: January 27, 2012
    Publication date: March 20, 2014
    Applicant: GAMMA VACCINES PTY LIMITED
    Inventors: Arno Mullbacher, Mohammed Alsharifi, Tim Hirst, Yoichi Furuya
  • Cross-Protective Influenza Vaccine
    Publication number: 20130122045
    Abstract: The invention relates to a method for preventing or treating an influenza virus infection in a subject, the method comprising administering to the subject a therapeutically effective amount of a gamma-irradiated influenza virus, wherein the virus comprises an A/Port Chalmers/1/73 (A/PC) strain backbone of PB2, PB1, PA, NP, M1, M2 and NEP proteins.
    Type: Application
    Filed: April 28, 2010
    Publication date: May 16, 2013
    Applicant: Gamma Vaccines Pty Limited
    Inventors: Tim Hirst, Mohammed Alsharifi, Arno Mullbacher
  • INFLUENZA VACCINES
    Publication number: 20110150926
    Abstract: The invention relates to a method for the treatment or prevention of an influenza virus infection in a subject, the method comprising administering to the subject a therapeutically effective amount of a gamma-irradiated influenza virus.
    Type: Application
    Filed: July 31, 2009
    Publication date: June 23, 2011
    Inventors: Mohammed Alsharifi, Arno Mullbacher
  • Immunoregulation
    Patent number: 4886796
    Abstract: A method of treating autoimmune diseases by suppressing the immune response of an animal is characterized by administering to the animal a compound of the general formula (1): ##STR1## wherein R.sup.0 and R.sup.1 are radicals selected from the group consisting of hydrogen, hydroxy, alkyl, alkoxy and acyloxy: R.sup.2 and R.sup.3 are radicals separately selected from the group consisting of hydrogen and alkyl; or together, represent a radical of the general formula (2): ##STR2## wherein R.sup.5, R.sup.6, R.sup.7, R.sup.8 and R.sup.9 are radicals separately selected from the group consisting of hydrogen, alkyl, hydroxy, alkoxy, sulfate, and halogen: or R.sup.2 and R.sup.3 together, represent a radical of the general formula (3): ##STR3## wherein R.sup.10 and R.sup.11 both represent hydrogen; or together, represent a valence bond: R.sup.12, R.sup.13, R.sup.14, R.sup.
    Type: Grant
    Filed: November 9, 1987
    Date of Patent: December 12, 1989
    Assignee: Australian National University
    Inventors: Ronald D. Eichner, Arno Mullbacher
  • Immunoregulation of transplantable tissue
    Patent number: 4727018
    Abstract: Donor tissue is treated prior to implantation in a recipient with a compound from the class known as epipolythiodioxopiperazines in order to prevent graft rejection.
    Type: Grant
    Filed: May 13, 1985
    Date of Patent: February 23, 1988
    Inventors: Ronald D. Eichner, Arno Mullbacher